insights_auto
Why is ARX up 8.16%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$0.53
arrow_upward
+8.16%(+0.040) 1D
Nov 6, 4:10:29 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.53
Low
A$0.46
Mkt. cap
181.46M
Avg. vol.
284.14K
Volume
553.67K
P/E ratio
51.36
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.53
Low
A$0.46
Mkt. cap
181.46M
Avg. vol.
284.14K
Volume
553.67K
P/E ratio
51.36
52-wk high
A$0.80
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
www.marketscreener.com
·
3 days ago
Aroa Biosurgery : Mark Dunwoodie appointed as Chief Financial Officer
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd